$15ISSN 2644-2787NOVEMBER - 11 - 2024www.pharmatechoutlook.comQuang X. Pham, Chairman and CEOCADRENAL THERAPEUTICS, INC. PIONEERING INNOVATION IN ANTICOAGULATION FOR RARE CARDIOVASCULAR CONDITIONSANTICOAGULATION THERAPY COMPANY OF THE YEAR2024(NASDAQ: CVKD)
Page 2 >